Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (46)

Advertisement

Research Article Free access | 10.1172/JCI113050

Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy.

P Pinkston, V K Vijayan, T B Nutman, W N Rom, K M O'Donnell, M J Cornelius, V Kumaraswami, V J Ferrans, T Takemura, and G Yenokida

Find articles by Pinkston, P. in: JCI | PubMed | Google Scholar

Find articles by Vijayan, V. in: JCI | PubMed | Google Scholar

Find articles by Nutman, T. in: JCI | PubMed | Google Scholar

Find articles by Rom, W. in: JCI | PubMed | Google Scholar

Find articles by O'Donnell, K. in: JCI | PubMed | Google Scholar

Find articles by Cornelius, M. in: JCI | PubMed | Google Scholar

Find articles by Kumaraswami, V. in: JCI | PubMed | Google Scholar

Find articles by Ferrans, V. in: JCI | PubMed | Google Scholar

Find articles by Takemura, T. in: JCI | PubMed | Google Scholar

Find articles by Yenokida, G. in: JCI | PubMed | Google Scholar

Published July 1, 1987 - More info

Published in Volume 80, Issue 1 on July 1, 1987
J Clin Invest. 1987;80(1):216–225. https://doi.org/10.1172/JCI113050.
© 1987 The American Society for Clinical Investigation
Published July 1, 1987 - Version history
View PDF
Abstract

Although acute tropical pulmonary eosinophilia (TPE) is well recognized as a manifestation of filarial infection, the processes that mediate the abnormalities of the lung in TPE are unknown. To evaluate the hypothesis that the derangements of the lower respiratory tract in this disorder are mediated by inflammatory cells in the local milieu, we utilized bronchoalveolar lavage to evaluate affected individuals before and after therapy. Inflammatory cells recovered from the lower respiratory tract of individuals with acute, untreated TPE (n = 8) revealed a striking eosinophilic alveolitis, with marked elevations in both the proportion of eosinophils (TPE 54 +/- 5%; normal 2 +/- 5%; P less than 0.001) and the concentration of eosinophils in the recovered epithelial lining fluid (ELF) (TPE 63 +/- 20 X 10(3)/microliter; normal 0.3 +/- 0.1 X 10(3)/microliter; P less than 0.01). Importantly, when individuals (n = 5) with acute TPE were treated with diethylcarbamazine (DEC), there was a marked decrease of the lung eosinophils and concomitant increase in lung function. These observations are consistent with the concept that at least some of the abnormalities found in the lung in acute TPE are mediated by an eosinophil-dominated inflammatory process in the lower respiratory tract.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 216
page 216
icon of scanned page 217
page 217
icon of scanned page 218
page 218
icon of scanned page 219
page 219
icon of scanned page 220
page 220
icon of scanned page 221
page 221
icon of scanned page 222
page 222
icon of scanned page 223
page 223
icon of scanned page 224
page 224
icon of scanned page 225
page 225
Version history
  • Version 1 (July 1, 1987): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (46)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts